OPUS GENETICS INC. -
1,0550
26-ноября-24 10:13:46
15 мин. задержка
Акции
-0,0450
-4,09%
Сегодняшний диапазон
1,0400 - 1,1143
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
22 июл 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Ocuphire Selected to Present at Multiple Ophthalmic Conferences in July
13 июл 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09 июл 2021 16:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire’s VEGA-1 Phase 2 Trial in Presbyopia Meets Primary and Secondary Endpoints
30 июн 2021 06:15:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Addition to the Russell Microcap® Index
11 июн 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market
08 июн 2021 15:10:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Appointment of Jay S. Pepose, M.D., Ph.D. to Its Board of Directors
08 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04 июн 2021 08:04:27 Источник Nasdaq GlobeNewswire
-
20 май 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
18 май 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
12 май 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update
07 май 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
22 апр 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
08 апр 2021 07:31:26 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 апр 2021 16:10:53 Источник Nasdaq GlobeNewswire
-
15 мар 2021 05:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Financial Results for the Full Year 2020 and Provides Corporate Update
10 мар 2021 15:30:00 Источник Nasdaq GlobeNewswire
-
05 мар 2021 07:44:07 Источник Nasdaq GlobeNewswire
-
Ocuphire to Participate in March Investor Conferences
04 мар 2021 07:27:09 Источник Nasdaq GlobeNewswire
-
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia
18 фев 2021 07:53:31 Источник Nasdaq GlobeNewswire